Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologic Therapy/Immunobiology
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Tocilizumab
•
Biologics
Do you use tocilizumab for the treatment of severe COVID-19 in patients who are on other biologics for rheumatic diseases, such as rituximab?
Related Questions
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
Can lupus anticoagulant be positive despite a normal aPTT?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
Would you use febuxostat for an African-American patient with gout and previous cardiovascular events (stroke, MI) who tested positive for HLA-B*5801?
What are your vaccine recommendations while patients are on biologics?
How do you treat nocturnal leg cramps?
How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?
